Camtek (NASDAQ:CAMT – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Needham & Company LLC in a report issued on Thursday,Benzinga reports. They currently have a $110.00 price objective on the semiconductor company’s stock. Needham & Company LLC’s price target would suggest a potential upside of 26.32% from the stock’s current price.
Other research analysts have also issued reports about the company. Northland Securities increased their price objective on Camtek from $102.00 to $120.00 and gave the company an “outperform” rating in a research report on Tuesday, January 7th. Cantor Fitzgerald initiated coverage on Camtek in a report on Monday, January 13th. They issued a “neutral” rating and a $100.00 price target on the stock. StockNews.com raised Camtek from a “sell” rating to a “hold” rating in a report on Wednesday, November 20th. Barclays reduced their target price on shares of Camtek from $140.00 to $120.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Finally, Stifel Nicolaus reissued a “buy” rating and set a $105.00 price target on shares of Camtek in a research note on Thursday, December 12th. Two analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $114.11.
Check Out Our Latest Report on CAMT
Camtek Stock Performance
Camtek (NASDAQ:CAMT – Get Free Report) last announced its earnings results on Wednesday, February 12th. The semiconductor company reported $0.68 earnings per share for the quarter, missing analysts’ consensus estimates of $0.74 by ($0.06). Camtek had a return on equity of 24.21% and a net margin of 26.53%. On average, research analysts anticipate that Camtek will post 2.53 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of CAMT. Advisors Asset Management Inc. increased its position in shares of Camtek by 78.8% during the third quarter. Advisors Asset Management Inc. now owns 329 shares of the semiconductor company’s stock worth $26,000 after acquiring an additional 145 shares in the last quarter. Jones Financial Companies Lllp boosted its stake in Camtek by 364.0% in the 4th quarter. Jones Financial Companies Lllp now owns 413 shares of the semiconductor company’s stock worth $33,000 after purchasing an additional 324 shares during the period. Huntington National Bank increased its holdings in Camtek by 42.4% during the 4th quarter. Huntington National Bank now owns 413 shares of the semiconductor company’s stock worth $33,000 after purchasing an additional 123 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in shares of Camtek in the 3rd quarter valued at about $53,000. Finally, Optimum Investment Advisors lifted its holdings in shares of Camtek by 43.3% in the fourth quarter. Optimum Investment Advisors now owns 2,150 shares of the semiconductor company’s stock valued at $174,000 after purchasing an additional 650 shares in the last quarter. Institutional investors own 41.93% of the company’s stock.
About Camtek
Camtek Ltd., together with its subsidiaries, develops, manufactures, and sells inspection and metrology equipment for semiconductor industry. The company provides Eagle-i, a system that delivers 2D inspection and metrology capabilities; Eagle-AP, which addresses the advanced packaging market using software and hardware technologies that deliver superior 2D and 3D inspection and metrology capabilities on the same platform; and Golden Eagle, a panel inspection and metrology system to address the challenges fanout wafer level packaging applications.
See Also
- Five stocks we like better than Camtek
- Most active stocks: Dollar volume vs share volume
- PayPal: Time to Strike With Shares Down Double Digits?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Lattice Semiconductor’s Market Reset Is Over: The Rebound Begins
- How to Use the MarketBeat Stock Screener
- Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial
Receive News & Ratings for Camtek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Camtek and related companies with MarketBeat.com's FREE daily email newsletter.